For healthcare professionals

A clinical solution you can trust.

PATI provides healthcare facilities and providers with an FDA cleared option for seizure oral trauma prevention. Finally, a clinically-backed solution to recommend to patients in need.

Patient Outcomes

Reduce oral trauma incidents in your patient population

Easy Institution Ordering

via renowned distribution partners

4 Step Simplified IFUs

for physician and patient use

FDA

Cleared Device

1st

of Its Kind

Manufactured

Patented

Our Team

The people behind PATI^®

Our leadership team combines firsthand patient experience with world-class expertise in healthcare, business, and innovation.

Dr. Ashlyn Sanders, MD

Founder & Chief Medical Officer

In 2014, Ashlyn was diagnosed with Chiari Malformation, requiring emergency brain surgery. She also experienced seizures—an experience that shaped her mission to improve the patient experience for millions living with neurologic disorders.

B.A. Mathematics (UNC Chapel Hill), M.A. Bioethics & Science Policy (Duke), Former White House Intern (Obama Administration)

Jordan Schindler

Chief Executive Officer

A recognized leader in HealthWear, Jordan has developed and launched innovative health products, scaling to eight-figure revenue and nationwide retail distribution at Walmart, Walgreens, and CVS.

#1 Fastest Growing Company (Charlotte Business Journal), #2 Fastest Growing Pharma Company in North America (Deloitte Fast 500), 5 U.S. Patents

Commercialized by

Blueprint Health Strategies Group is an execution-led commercialization partner delivering end-to-end support across the full product lifecycle.
‍Blueprint bridges the critical gap between strategy and execution by combining rigorous market insight with hands-on operational leadership. Operating as an extension of the executive team, they help companies navigate capital formation, launch readiness, commercial scale, and investor scrutiny.